Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
CNS Pharmaceuticals, Inc. (CNSP) had Return on Equity of -240.55% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-14.86M |
|
-- |
|
-- |
|
$14.90M |
|
$-14.90M |
|
$0.04M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.90M |
|
$-14.90M |
|
0.38M |
|
0.38M |
|
$-38.87 |
|
$-38.87 |
|
| Balance Sheet Financials | |
$8.66M |
|
$0.01M |
|
$0.04M |
|
$8.70M |
|
$2.52M |
|
-- |
|
-- |
|
$2.52M |
|
$6.18M |
|
$6.18M |
|
$6.18M |
|
1.41M |
|
| Cash Flow Statement Financials | |
$-17.11M |
|
$-0.00M |
|
$23.03M |
|
$0.55M |
|
$6.46M |
|
$5.91M |
|
$1.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.43 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-240.55% |
-240.55% |
|
-170.76% |
|
-240.55% |
|
$4.37 |
|
$-44.81 |
|
$-44.80 |
|